Development of polyvinylpyrrolidone/paclitaxel self-assemblies for breast cancer

Bibliographic Details
Title: Development of polyvinylpyrrolidone/paclitaxel self-assemblies for breast cancer
Authors: Pallabita Chowdhury, Prashanth K.B. Nagesh, Sheema Khan, Bilal B. Hafeez, Subhash C. Chauhan, Meena Jaggi, Murali M. Yallapu
Source: Acta Pharmaceutica Sinica B, Vol 8, Iss 4, Pp 602-614 (2018)
Publisher Information: Elsevier, 2018.
Publication Year: 2018
Collection: LCC:Therapeutics. Pharmacology
Subject Terms: Therapeutics. Pharmacology, RM1-950
More Details: The goal of this investigation was to develop and demonstrate a polymer/paclitaxel self-assembly (PTX-SA) formulation. Polymer/PTX-SAs were screened based on smaller size of formulation using dynamic light scattering analysis. Additionally, fluorescence microscopy and flow cytometry studies exhibited that polyvinylpyrrolidone (PVP)-based PTX-SAs (PVP/PTX-SAs) had superior cellular internalization capability in MCF7 and MDA-MB-231 breast cancer cells. The optimized PVP/PTX-SAs exhibited less toxicity to human red blood cells indicating a suitable formulation for reducing systemic toxicity. The formation of PVP and PTX self-assemblies was confirmed using fluorescence quenching and transmission electron microscopy which indicated that the PVP/PTX-SAs were spherical in shape with an average size range of 53.81 nm as detected by transmission electron microscopy (TEM). FTIR spectral analysis demonstrates incorporation of polymer and paclitaxel functional groups in PVP/PTX-SAs. Both proliferation (MTS) and clonogenic (colony formation) assays were used to validate superior anticancer activity of PVP/PTX-SAs in breast cancer cells over paclitaxel. Such superior anticancer activity was also demonstrated by downregulation of the expression of pro-survival protein (Bcl-xL), upregulation of apoptosis-associated proteins (Bid, Bax, cleaved caspase 7, and cleaved PARP) and β-tubulin stabilization. These results support the hypothesis that PVP/PTX-SAs improved paclitaxel delivery to cancer cells. KEY WORDS: Drug delivery, Nanoparticles, Self-assemblies, Polymer, Cancer therapeutics, Breast cancer
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2211-3835
Relation: http://www.sciencedirect.com/science/article/pii/S2211383517303933; https://doaj.org/toc/2211-3835
DOI: 10.1016/j.apsb.2017.10.004
Access URL: https://doaj.org/article/51d32e5aba2b4104bd7cbbecd93fad9d
Accession Number: edsdoj.51d32e5aba2b4104bd7cbbecd93fad9d
Database: Directory of Open Access Journals
More Details
ISSN:22113835
DOI:10.1016/j.apsb.2017.10.004
Published in:Acta Pharmaceutica Sinica B
Language:English